Drug combo shows promise in bile duct cancer with mutations
Article written by Bruce Sylvester Dabrafenib plus trametinib combination appears to be a promising treatment for patients with bile duct cancer (biliary tract cancer) with BRAF V600E mutations. Researchers… read more.